Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
PLoS One ; 8(4): e60221, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23613721

RESUMEN

Antiviral provision remains the focus of many pandemic preparedness plans, however, there is considerable uncertainty regarding antiviral compliance rates. Here we employ a waste water epidemiology approach to estimate oseltamivir (Tamiflu®) compliance. Oseltamivir carboxylate (oseltamivir's active metabolite) was recovered from two waste water treatment plant (WWTP) catchments within the United Kingdom at the peak of the autumnal wave of the 2009 Influenza A (H1N1)pdm09 pandemic. Predictions of oseltamivir consumption from detected levels were compared with two sources of national government statistics to derive compliance rates. Scenario and sensitivity analysis indicated between 3-4 and 120-154 people were using oseltamivir during the study period in the two WWTP catchments and a compliance rate between 45-60%. With approximately half the collected antivirals going unused, there is a clear need to alter public health messages to improve compliance. We argue that a near real-time understanding of drug compliance at the scale of the waste water treatment plant (hundreds to millions of people) can potentially help public health messages become more timely, targeted, and demographically sensitive, while potentially leading to less mis- and un-used antiviral, less wastage and ultimately a more robust and efficacious pandemic preparedness plan.


Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/fisiología , Gripe Humana/epidemiología , Cumplimiento de la Medicación/estadística & datos numéricos , Oseltamivir/análisis , Oseltamivir/uso terapéutico , Pandemias , Aguas Residuales/química , Antivirales/análisis , Antivirales/farmacología , Antivirales/uso terapéutico , Humanos , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Gripe Humana/tratamiento farmacológico , Oseltamivir/farmacología , Estadística como Asunto , Reino Unido
2.
Water Res ; 44(2): 649-57, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19942249

RESUMEN

Concentrations of six pharmaceutical antimycotics were determined in the sewage water, final effluent and sludge of five Swedish sewage treatment plants (STPs) by solid phase extraction, liquid/solid extraction, and liquid chromatography-electrospray tandem mass spectrometry. The antimycotics were quantified by internal standard calibration. The results were used to estimate national flows that were compared to predictions based on sales figures. Fluconazole was the only one of the six investigated antimycotics that was detected (at concentrations ranging from 90 to 140 ng L(-1)) in both raw sewage water and final effluent. Negligible amounts of this substance were removed from the aqueous phase, and its levels were below the limit of quantification in all of the analyzed sludge samples. In contrast, clotrimazole, ketoconazole and econazole were present in all of the sludge samples, at concentrations ranging between 200 and 1000 microg kg(-1), dry weight. There were close correlations between the national measured and predicted antimycotic mass flows. Antimycotic fate analysis, based on sales figures, indicated that 53% of the total amount of fluconazole sold appeared in the final effluents of the STPs, while 1, 155, 35, 209 and 41% of the terbinafine, clotrimazole, ketoconazole, econazole and miconazole sold appeared in the digested dewatered sludge.


Asunto(s)
Antifúngicos/análisis , Aguas del Alcantarillado/química , Contaminantes Químicos del Agua/análisis , Antifúngicos/química , Clotrimazol/análisis , Clotrimazol/química , Econazol/análisis , Econazol/química , Monitoreo del Ambiente , Fluconazol/análisis , Fluconazol/química , Cetoconazol/análisis , Cetoconazol/química , Miconazol/análisis , Miconazol/química , Naftalenos/análisis , Naftalenos/química , Suecia , Terbinafina , Eliminación de Residuos Líquidos , Contaminantes Químicos del Agua/química
3.
Water Res ; 41(3): 613-9, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17187841

RESUMEN

The potential risks associated with antibiotics present in the Swedish environment were assessed using concentrations found in hospital effluent, and sewage treatment waters and sludge, in combination with data on their environmental effects obtained from the literature. For the aqueous environment, measured environmental concentrations and effect/no observed effect concentration ratios were much lower than one in most cases. The only exceptions, where concentrations of the investigated substances were high enough to pose potential risks, were the concentrations of the two fluoroquinolones, ofloxacin and ciprofloxacin, in the hospital effluent. Treating digested dewatered sludge by heat did not fully eliminate norfloxacin or ciprofloxacin, thus pellets may still contain high amounts of these substances (sub to low mgkg(-1)dw). In leaching tests less than 1% of the amounts of these fluoroquinolones in the sludge or pellets reached the aqueous phase, indicating that their mobility is limited if sludge is used to fertilize soil.


Asunto(s)
Antibacterianos/análisis , Aguas del Alcantarillado/análisis , Contaminación Química del Agua/análisis , Ciprofloxacina/análisis , Monitoreo del Ambiente/métodos , Fluoroquinolonas/análisis , Geografía , Norfloxacino/análisis , Suecia , Eliminación de Residuos Líquidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA